Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Potent Anti-Glioblastoma Effects of Next-Generation MNK Inhibitors.

Cancers·2026

Same author

SLFN5 restrains type I interferon responses and promotes glioblastoma via its N-terminal Schlafen core domain.

Communications biology·2026

Same author

Mitochondrial L-2-hydroxyglutarate is a physiological signalling metabolite.

Nature·2026

Same author

Multi-omics analysis reveals LARP1 as a key integrator of translation and metabolism in AML.

Oncogenesis·2026

Same author

Artificial intelligence differentiates prefibrotic primary myelofibrosis with thrombocytosis from essential thrombocythemia using digitized bone marrow biopsy images.

Leukemia·2026

Same author

Trimodal single-cell profiling of transcriptome, epigenome and 3D genome in complex tissues with scHiCAR.

Nature biotechnology·2026

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells.

Diana Saleiro^1,2, Ewa M Kosciuczuk^1,2,3, Mariafausta Fischietti^1,2

¹Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois.

Cancer Research Communications

|June 28, 2023

Summary

Chromatin assembly factor 1 subunit B (CHAF1B) is overexpressed in myeloproliferative neoplasms (MPN). Silencing CHAF1B enhances interferon-alpha (IFNα) therapy, offering a new treatment strategy for MPN patients.

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

Published on: May 31, 2020

Related Experiment Videos

Last Updated: Jun 14, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

Published on: May 31, 2020

Area of Science:

Immunology
Molecular Biology
Oncology

Background:

Interferons (IFNs) are cytokines with known antineoplastic and antiviral properties.
Interferon-alpha (IFNα) shows clinical efficacy in treating myeloproliferative neoplasms (MPN), but its mechanisms remain unclear.
Chromatin assembly factor 1 subunit B (CHAF1B) is identified as an Unc-51-like kinase 1 (ULK1)-interacting protein in malignant cells.

Purpose of the Study:

To investigate the role of CHAF1B in MPN pathogenesis.
To explore CHAF1B as a potential therapeutic target in MPN.
To determine if CHAF1B inhibition can enhance IFNα efficacy.

Main Methods:

Analysis of CHAF1B expression in MPN patients.
Targeted silencing of CHAF1B in primary MPN progenitor cells.
Assessment of IFNα-stimulated gene transcription and antineoplastic responses.

Main Results:

CHAF1B is overexpressed in patients with MPN.
Targeted silencing of CHAF1B significantly enhances transcription of IFNα-stimulated genes.
CHAF1B inhibition promotes IFNα-dependent antineoplastic responses in MPN progenitor cells.

Conclusions:

CHAF1B is a promising therapeutic target for MPN.
Inhibiting CHAF1B in combination with IFNα therapy presents a novel treatment strategy for MPN.
These findings have significant clinical translational implications for MPN and potentially other malignancies.